Drugs in pregnancy: anticonvulsants (Q41513746)

2 October 2017

1 reference

title

Drugs in pregnancy: anticonvulsants (English)

1 reference

2 October 2017

2

D'Alton ME

1 reference

2 October 2017

1

Malone FD

1 reference

2 October 2017

1 April 1997

1 reference

2 October 2017

Seminars in Perinatology

1 reference

2 October 2017

21

1 reference

2 October 2017

2

1 reference

2 October 2017

114-123

1 reference

Pregnancy, teratogenesis, and epilepsy.

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Women with epilepsy. Reproduction and effects of pregnancy on epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Facial clefts in sibs and children of epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Prenatal prediction of risk of the fetal hydantoin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Anticonvulsants, folate levels, and pregnancy outcome: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

1 reference

7 January 2021

Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Phenytoin teratogenicity in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Fetal hydantoin syndrome and neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Neonatal hypocalcaemia after intrauterine exposure to anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Outcomes of pregnancy associated with antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Antiepileptic medication in pregnancy: late effects on the children's central nervous system development.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Maternal barbiturate utilization and neonatal withdrawal symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

The fetal valproate syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Neonatal afibrinogenaemia due to sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Sodium valproate, pregnancy, and infantile fatal liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Spina bifida in infants of women treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Teratogenic effects of carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

The fetal trimethadione syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

Absence of Need for Amniocentesis in Patients with Elevated Levels of Maternal Serum Alpha-Fetoprotein and Normal Ultrasonographic Examinations

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980054-7

7 January 2021

10.1016/S0146-0005(97)80054-7

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9201817